¥13.58 ($2.03)

+0.79 (+6.18%)

SHZ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 60 · ¥15.2B mcap · 602M float · 3.31% daily turnover

Revenue

$2.7B -23.7% ▼

5Y CAGR: +6.4%

Gross Profit

$2.0B -30.9% ▼

5Y CAGR: +2.0%

Operating Income

$181M -80.9% ▼

5Y CAGR: -22.7%

Net Income

$202M -76.6% ▼

5Y CAGR: -18.9%

EPS (Diluted)

$0.18 -76.6% ▼

5Y CAGR: -20.3%

EBITDA

$441M -55.0% ▼

5Y CAGR: -8.7%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$2.3B	$3.7B	$3.2B	$3.5B	$2.7B
YoY Growth	+16.4%	+61.5%	-13.5%	+10.1%	-23.7%
Cost of Revenue	$247M	$1.1B	$775M	$655M	$701M
Gross Profit	$2.0B	$2.5B	$2.4B	$2.8B	$2.0B
Gross Margin	89.1%	68.6%	75.5%	81.2%	73.6%
R&D Expenses	$267M	$354M	$802M	$501M	$508M
SG&A Expenses	$1.0B	$820M	$1.3B	$1.5B	$1.3B
Operating Expenses	$1.2B	$1.1B	$2.7B	$1.9B	$1.8B
Operating Income	$775M	$1.5B	-$318M	$949M	$181M
Operating Margin	34.3%	39.8%	-10.1%	27.3%	6.8%
Interest Expense	$2M	$55M	$110M	$114M	$125M
Income Before Tax	$772M	$1.4B	-$338M	$940M	$150M
Tax Expense	$93M	$176M	-$206M	$79M	-$52M
Net Income	$679M	$1.3B	-$133M	$861M	$202M
Net Margin	30.0%	34.6%	-4.2%	24.8%	7.6%
EPS (Diluted)	$0.63	$1.14	$-0.12	$0.77	$0.18
EBITDA	$775M	$1.7B	$406M	$980M	$441M
Shares Outstanding	1.08B	1.11B	1.11B	1.12B	1.12B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$816M	$634M	$645M	$747M	$671M	$610M	$631M	$642M
Cost of Revenue	$75M	$367M	$171M	$258M	$111M	$136M	$182M	$219M
Gross Profit	$741M	$267M	$474M	$489M	$560M	$473M	$449M	$423M
Gross Margin	90.8%	42.1%	73.5%	65.5%	83.5%	77.6%	71.1%	65.9%
R&D Expenses	$92M	$196M	$121M	$176M	$123M	$123M	$84M	$91M
SG&A Expenses	$344M	$337M	$291M	$336M	$291M	$13M	$303M	$299M
Operating Expenses	$543M	$427M	$446M	$515M	$556M	$441M	$400M	$417M
Operating Income	$198M	-$160M	$28M	-$26M	$4M	$32M	$48M	$6M
Operating Margin	24.3%	-25.2%	4.4%	-3.5%	0.6%	5.3%	7.7%	0.9%
Interest Expense	$30M	$31M	$29M	$29M	$30M	$30M	$29M	$30M
Income Before Tax	$198M	-$185M	$27M	-$27M	$324K	$45M	$40M	$1M
Tax Expense	$12M	-$35M	$5M	-$42M	-$11M	$24M	$6M	-$13M
Net Income	$186M	-$149M	$22M	$15M	$12M	$21M	$33M	$17M
Net Margin	22.8%	-23.6%	3.5%	2.0%	1.7%	3.5%	5.3%	2.7%
EPS (Diluted)	$0.17	$-0.13	$0.02	$0.01	$0.01	$0.02	$0.03	$0.02
EBITDA	$349M	-$194M	$127M	$41M	$108M	$222M	$69M	$113M
Shares Outstanding	1.12B	1.12B	1.12B	1.12B	1.18B	1.12B	1.12B	1.12B

300601.SZ SHZ